Get started
Neuronetics, Inc.Neuronetics, Inc.Neuronetics, Inc.

Neuronetics, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Neuronetics, Inc.



Key facts today


Neuronetics (STIM) said EVP and Chief Legal Officer W. Andrew Macan will leave effective August 15, 2026. Company gave no details on a successor, transition, severance, or governance impact. 1
Neuronetics granted Naor 500,000 restricted stock units (RSUs) as an inducement. RSUs vest in four equal annual installments starting one year after hire, contingent on continued employment. 1
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪112.73 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.55 USD
Net income (FY)
‪−39.00 M‬ USD
Revenue (FY)
‪149.16 M‬ USD
Shares float
‪24.72 M‬
Beta (1Y)
2.43

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
658
Change (1Y)
−58−8.10%
Revenue / Employee (1Y)
‪226.68 K‬ USD
Net income / Employee (1Y)
‪−59.27 K‬ USD

Profile


Sector
Health Technology
Industry
Medical Specialties
CEO
Daniel L. Reuvers
Website
neurostar.com
Headquarters
Malvern
Founded
1998
IPO date
Jun 28, 2018
ISIN
US64131A1051
CUSIP
64131A105
FIGI
BBG000QX36J1
Identifiers
ISIN US64131A1051
CFI code
ESVUFR
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


PSIL
AdvisorShares Psychedelics ETF
Weight3.38%
Market value‪1.55 M‬
QQQS
Invesco NASDAQ Future Gen 200 ETF
Weight0.68%
Market value‪146.68 K‬

Explore more ETFs 

Frequently asked questions


The current price of STIM is 2.00 USD — it has increased by 24.69% in the past 24 hours. Watch Neuronetics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Neuronetics, Inc. stocks are traded under the ticker STIM.
STIM stock has risen by 18.13% compared to the previous week, the month change is a 64.23% rise, over the last year Neuronetics, Inc. has showed a −45.79% decrease.
We've gathered analysts' opinions on Neuronetics, Inc. future price: according to them, STIM price has a max estimate of 7.00 USD and a min estimate of 3.00 USD. Watch STIM chart and read a more detailed Neuronetics, Inc. stock forecast: see what analysts think of Neuronetics, Inc. and suggest that you do with its stocks.
STIM reached its all-time high on Sep 7, 2018 with the price of 39.39 USD, and its all-time low was 0.52 USD and was reached on Nov 12, 2024. View more price dynamics on STIM chart.
See other stocks reaching their highest and lowest prices.
STIM stock is 8.75% volatile and has beta coefficient of 2.43. Track Neuronetics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Neuronetics, Inc. there?
Today Neuronetics, Inc. has the market capitalization of ‪123.87 M‬, it has decreased by −9.50% over the last week.
Yes, you can track Neuronetics, Inc. financials in yearly and quarterly reports right on TradingView.
Neuronetics, Inc. is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
STIM earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.17 USD resulting in a 8.20% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Neuronetics, Inc. earnings.
Neuronetics, Inc. revenue for the last quarter amounts to ‪34.45 M‬ USD, despite the estimated figure of ‪34.17 M‬ USD. In the next quarter, revenue is expected to reach ‪40.09 M‬ USD.
STIM net income for the last quarter is ‪−10.79 M‬ USD, while the quarter before that showed ‪−7.16 M‬ USD of net income which accounts for 0.00% change. Track more Neuronetics, Inc. financial stats to get the full picture.
No, STIM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 658 employees. See our rating of the largest employees — is Neuronetics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Neuronetics, Inc. EBITDA is ‪−26.12 M‬ USD, and current EBITDA margin is −18.75%. See more stats in Neuronetics, Inc. financial statements.
Like other stocks, STIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neuronetics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neuronetics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neuronetics, Inc. stock shows the sell signal. See more of Neuronetics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.